FOI/2025/26/276
Read more about this page below
| Reference | FOI/2025/26/276 |
|---|---|
| Description | Hemophilia Data |
| Date requested | 10/11/2025 |
| Attachments | N/A |
Request
Please provide Hemophilia A patient numbers broken down by: age, disease severity and treatment regimen (PPx denotes use for prophylaxis and OD denotes use on demand). I have proposed a format below to capture the relevant information. If data is not available by age breakdown, then please provide aggregated total in the yellow highlighted column
For Hemlibra-treated Hemophilia A Inhibitor patients, please indicate the number of patients by age group and dosing frequency for Q3’25 (July–September 2025). If data is not available by age breakdown then please provide aggregated total:
For Hemlibra-treated Hemophilia A non-inhibitor patients, please indicate the number of patients by age group and dosing frequency for Q3’25 (July–September 2025). If data is not available by age breakdown then please provide aggregated total:
Response
Having carried out enquiries within the relevent services, Central London Community Healthcare NHS Trust does not have any patients registered for Hemophilia.